《大行報告》中金升太航(02343.HK)目標價至4.6元 評級「跑贏行業」
中金髮表報告,指太平洋航運(02343.HK)公佈第三季度運營數據,小靈便型及超靈便型乾散貨船按期租合約對等基準的日均收入分別爲24,350美元及36,270美元,對應按年增長204%及224%,較2021年上半年分別增長69%及99%。
考慮到公司因運費上漲而帶來的盈利增長空間,中金上調太航2021年和2022年盈測分別44%和40%,至7.03億美元和7.22億美元,維持「跑贏行業」評級。考慮到乾散即期運費的歷史波動較大,上調目標價11%至4.6港元,相當於今明兩年預測市盈率4倍及3.9倍;並預計公司派息比率將維持在50%以上,對應2021年股息收益率16.6%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.